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ABSTRACT
Conventional optical coherence tomography
(OCT) enables the visualization of morphologi-
cal changes of skin cancer. The use of OCT in
the diagnostic investigation and in the therapy
decision of non-melanoma skin cancer and
other skin changes is already established, and
has found its way into routine practice. With
the development of speckle-variance OCT, also
named dynamic OCT (D-OCT), the vascular
architecture and the blood flow of the skin can
be displayed in vivo and in 3D. This novel
angiographic variant of OCT offers the ability to
visualize and measure vessel morphology pro-
viding a new insight into healthy, inflamma-
tory and neoplastic skin lesions such as
malignant melanoma. This review focuses on
the possibilities of using D-OCT on healthy and
diseased skin. We suggest and illustrate key
diagnostic characteristics by analyzing the ini-
tial publications and preliminary unpublished
data on vessel morphology and distribution.
The potential of D-OCT as a diagnostic tool in
dermatology is examined and may give rise to
future studies on D-OCT, which are needed to
confirm the aforementioned features.
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INTRODUCTION
Optical coherence tomography (OCT) is a non-
invasive imaging technique that has been
applied to skin since 1997 [1]. It provides
two-dimensional cross-sectional and horizontal
images of skin areas covering several square
millimeters with a penetration depth of up to
1.5 mm. The OCT images are displayed in real
time, showing architectural changes of the skin
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layers. In most cases, the resolution of 3–15 lm
is not high enough to distinguish single cells.
In dermatology, conventional OCT is mainly
used and is already well established in the
diagnosis of epithelial skin cancer such as basal
cell carcinomas with good sensitivity (96%) and
specificity (75%) [2]. Basal cell carcinomas show
typical features such as ovoid ‘nests’ with a dark
rim, and can be easily differentiated from acti-
nic keratoses. Some variants of OCT have been
developed, including ‘high-definition OCT’ in
which greater optical resolution is obtained
with a higher optical power objective lens at the
expense of lower image penetration depth and
reduced field of view, and ‘en-face’ OCT in
which a ‘top–down’ view of the tissue at a given
depth is viewed.
OCT is a ‘passive’ imaging technique that
does not require a contrast agent. It cannot
detect fluorescent markers. Its imaging depth of
0.5–1 mm is considerably higher than reflec-
tance confocal microscopy (RCM),\0.2 mm [3],
but, unlike RCM, it cannot resolve individual
cells. The image resolution and contrast of OCT
is considerably higher than ultrasound. OCT is
ideal for imaging subsurface skin microstructure
in the epidermis and upper dermis. In this
review, we will use the term ‘structural OCT’ for
all of the above described variants of OCT,
because they all detect and image tissue
structure.
Structural OCT has been found not to be
suitable for diagnosing melanoma, because the
images have not shown any features that could
enable differentiation between malignant mel-
anomas from dysplastic nevi. However, a novel
variation of OCT has recently emerged which
shows considerable promise in changing this
unsatisfactory situation. This newly developed
technique is variously called speckle-variance
OCT [4], optical microangiography [5], or
dynamic OCT (D-OCT) [6]. It relies on detecting
motion in the OCT images: OCT images of the
exact same site are captured at a high frame rate
and then changes between consecutive OCT
image frames are detected, so that moving par-
ticles can be distinguished from the static tissue
signal. This particle motion corresponds to
blood flow, and so D-OCT when coupled with
structural OCT reveals both the tissue structure
and the morphology of the blood vessel struc-
ture in the imaged region. Thus, by using
D-OCT to additionally image the blood vessels
in skin lesions, it seems feasible that the utility
of OCT could be extended to include diagnosis/
prognosis of malignant melanoma and other
skin pathologies.
The current review focuses on initial findings
using a commercially available, CE-marked
D-OCT device, starting with imaging of healthy
skin, and moving on to D-OCT images of
non-melanoma skin cancer, melanocytic
lesions, and then a variety of other conditions
chosen by us. For each lesion class, we also
briefly review the key features visible in struc-
tural OCT images. The work was supported by
funds from the European Union (ADVANCE,
Automatic Detection of VAscular Networks for
Cancer Evaluation, Grant No. 621015). The core
aim of the ADVANCE project was to investigate
the vasculature in malignant melanomas and
correlate the patterns to known risk factors and
prognosis.
METHODS
The device used in the ADVANCE project was a
VivoSight Dx multi-beam OCT dermatological
scanner (Michelson Diagnostics, Maidstone,
UK) equipped with proprietary Dynamic OCT
imaging software. The optical resolution of the
scanner is 7.5 lm in the lateral direction and
5 lm in the axial direction. This is sufficient to
clearly show fine details of skin morphology
and also fine blood vessels, but not high enough
to reveal individual cells. The field of view of
the probe is 6 mm 9 6 mm and the imaging
depth is between 1.0 and 2.0 mm. The hand-
held probe is equipped with a color camera to
aid accurate placement on a lesion and to pro-
vide a context picture. No gel or other prepa-
ration of the skin is required, the imaging
procedure is straightforward and simply
requires a steady pair of hands.
The OCT laser wavelength is 1300 nm
(near-IR) at which melanin is transparent, and
so the imaging works well in skin of any ethnic
type and even on strongly pigmented lesions.
One OCT image appears as a vertical slice into
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the skin, 6 mm wide and up to 2 mm deep.
However, in one 30-s scan, 120 such individual
images are captured as a 6 9 6 9 2 mm
(w 9 l 9 d) ‘stack’ of images, which are then
automatically processed to also show the hori-
zontal plane view. The stack can then be eval-
uated in both horizontal and vertical view
simultaneously at any desired depth.
The Dynamic OCT algorithm used
in VivoSight is tuned to preferentially detect
movement due to blood flow, rather than due
to small bulk movement of the probe caused by
small involuntary movements of the operator or
patient. The software displays the detected areas
of motion as a red overlay on the standard grey
OCT image, with red brightness corresponding
to the strength of the blood flow. The horizon-
tal plane view has been further enhanced by
fitting the imaging plane to the skin surface, so
that the displayed top-view image comprises
pixels at any desired exact depth below the skin
surface. This is termed the ‘fitted plane’ and is
useful because skin is far from flat, having
wrinkles, bumps and so on, and the vascular
plexus tends to follow the surface topography.
Thus, Dynamic OCT can reveal the pattern of
surface blood vessels and also be used to mea-
sure their exact depth, and to provide an indi-
cation of the strength of blood flow in the
vessels. The Dynamic OCT algorithm works well
at depths of up to about 0.5 mm; at greater
depths, there is too much interference in the
signal by background noise. It is hoped that
further developments in image processing will
extend the useful depth in the future. This
article is based on previously conducted studies
and does not involve any new studies of human
or animal subjects performed by any of the
authors.
RESULTS
Healthy Skin in Different Locations
Former studies have already shown that healthy
skin has a different appearance in structural
OCT depending on the various anatomical
locations [7, 8]. However, the typical structure
of the skin, which the vertical sections of OCT
images visualize, stays mainly the same. Below
the entrance signal, which is responsible for the
first thin dark layer in OCT pictures, there is the
stratum corneum [7]. This can only be seen in
palmoplantar skin and appears as a thick,
low-echoic layer, consisting of highly scatter-
ing, convoluted sweat gland ducts [7, 8]. Next,
the epidermis is depicted in the OCT image,
which appears hypo-reflective compared to the
more signal-intense dermis. The dermoepider-
mal junction (DEJ) stands out as a thin line
between the darker epidermis and the lighter
dermis. The hyper-reflective dermis also con-
tains parts with lower signal intensity like
sebaceous glands, hair follicles or vessels [7].
Turning to D-OCT, Themstrup et al. showed
that D-OCT can reliably depict and determine
the vasculature and its changes in normal skin
due to physiological influences on the blood
flow [9]. The information about vasculature is
added to the structure of the common OCT
image. Due to the distinct body regions and
their local external and internal influences, the
vascular network appears different. For exam-
ple, in the en face D-OCT image, the healthy
skin of the face shows a broader net of the ves-
sels and also an enlargement of the single ves-
sels compared to other body parts (Fig. 1a). The
vessels at the fingertips are organized in the
form of a live in vivo fingerprint and can
therefore be easily discriminated from other
vascular networks in the horizontal display
(Fig. 1b). In the en face view, the vasculature of
healthy skin on the legs seems to follow a
reticular order, while the vessels of normal skin
on the arms and the trunk are of comma- and
dot-like shapes (Fig. 1c–e). At the nail fold, the
vessels are arranged parallel to the skin surface
(Fig. 1f). Anatomical variations of the epidermal
thickness should also be kept in mind, since the
vessels pop up at different levels below the
surface in the D-OCT images.
In order to fully understand the vascular
network, not only the anatomical but also the
physiological influences on vasculature and
microcirculation have to be taken into account.
The vascular architecture is characterized by
two plexuses, which are aligned parallel to the
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surface of the skin. The superficial plexus
between the papillary and reticular dermis is the
source of the capillary loops for the papillae,
which nurture the avascular epidermis [10].
These loops demarcate as small dots along the
DEJ in vertical D-OCT images (Fig. 2). The pro-
found plexus between the dermis and subcutis
connects with the superficial plexus through
vertical vessels in a healthy state.
In general, normal skin can be detected in
D-OCT based on a well-arranged vascular pat-
tern and each of the vessels is clearly visible in
the en face images. These two characteristics
need to be considered in order to distinguish
the vasculature of healthy skin from diseased
skin.
Skin Tumors
Actinic Keratosis, Bowen’s Disease, Invasive
Squamous Cell Carcinoma
In structural OCT images, actinic keratoses (AK)
show a thickening of the stratum corneum and
of the epidermis. All layers can be discriminated
from each other and the DEJ is demarcated as a
dark line between the epidermis and dermis.
There are varying degrees of hyperkeratosis, for
example the highly reflecting forms which are
often found in thick hyperkeratotic AK, but also
variants of hypo-reflection due to parakeratosis.
D-OCT depicts the vasculature of AK in the en
face view as a reticular pattern with more and
slightly larger vessels and in greater disarray
Fig. 1 The skin depth of all depicted images is 0.4 mm.
a Normal skin on the left cheek (size: 6 mm 9 6 mm, en
face view). A broader, but regular vascular network and
thicker single vessels in the face in comparison to other
body parts can be seen. b Healthy skin on the fingertip of
the left index finger (size: 6 mm 9 6 mm, en face view).
The vessels are arranged in the form of a live in vivo
fingerprint. c–e Normal skin on the right leg, left arm and
trunk (size: 6 mm 9 6 mm, en face view). The vasculature
of healthy skin on the legs is organized in a reticular
pattern, the vessels of normal skin on the arms and the
trunk come in form of commas and dots. f Normal skin on
the left nail fold of the left index finger (size:
6 mm 9 6 mm, en face view). At the nail fold, the vessels
are arranged parallel to the skin surface
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compared to healthy skin (Fig. 3a). Thick and
thin branching vessels are present [11].
In conventional OCT, Bowen’s disease/
squamous cell carcinoma (SCC) in situ have a
lot in common with AK, since there is, for
example, also a visible increase in epidermal
thickness. Typical features like hyperkeratotic
scales appear less thick or are even absent. But
with D-OCT, it might be possible to differenti-
ate between the two skin tumor entities by the
vasculature. The vascular network in Bowen’s
disease/SCC in situ has a more grainy
appearance with vessels in the form of dots,
blobs and sometimes curves, dependent on the
skin depth of the image (Fig. 3b). Overall, the
dot-like vessels in Bowen’s disease/SCC in situ
are larger than in healthy or psoriatic skin.
Invasive SCC, in situ SCC and AK with thick
hyperkeratotic scales are very difficult to dis-
criminate with structural OCT images mainly
because the hyperkeratosis makes it nearly
impossible to get an insight into deeper skin
layers and the DEJ is also obscured. In the
structural OCT images, the diagnostician has to
Fig. 2 Normal skin on the right leg (size: 6 mm 9 2 mm,
vertical view). The capillary loops for the papillae, which
supply the avascular epidermis and arise from the super-
ficial plexus, are shown as small dots along the DEJ
(arrows) in vertical D-OCT images. The vertical stripes at
the base of the image are artifacts of the processing
algorithm and can be ignored
Fig. 3 a AK on the forehead (size: 6 mm 9 6 mm, en face
view). The skin depth of the depicted image is 0.3 mm.
The vessels in AK are arranged in a reticular network with
more and slightly bigger vessels in contrast to normal skin.
b Bowen’s disease/SCC in situ on the left hand
(size: 6 mm 9 6 mm, en face view). The skin depth of
the depicted image is 0.2 mm. The vasculature of Bowen’s
disease/SCC in situ mainly consists of dots, blobs and less
curved vessels and is not organized in a network. c Invasive
SCC on the left cheek (size: 6 mm 9 6 mm, en face view).
The skin depth of the depicted image is 0.4 mm. The
vascular network of invasive SCC is of irregular morphol-
ogy with diffusely organized vessels in changing diameters
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identify specific characteristics of invasive SCC
such as the alteration or loss of the normally
visible DEJ as well as the disruption of the der-
mis and/or of regular skin layers, which can also
be noticed in AK/SCC in situ. In the dermis,
protrusions from the epidermis invading the
dermis show various shapes of different signal
intensity. With D-OCT, the dynamic mode adds
information on the vasculature to the structural
images. The vessels of invasive SCC appear in
different irregular forms and patterns on the
one hand and show changes in vessel diameters
on the other (Fig. 3c).
Basal Cell Carcinoma
BCC is the most common skin cancer and also
the most frequent non-melanocytic skin cancer.
The most important risk factor for BCC is UV
irradiation [12]. Initially, the BCC can be clini-
cally detected as small, highly demarcated,
translucent or pearly nodules, papules, scars or
ulcerations with typical teleangiectasia [12, 13].
There are different subtypes of BCC with asso-
ciated risks of recurrences [14]. BCC grow
slowly, but, in the absence of treatment, the
tumor can expand in the vertical as well as the
horizontal direction and lead to destruction of
tissue or even bones [13]. The rate of metastasis
is very low and thus BCCs are sometimes called
semi-malignant tumors [12].
In structural OCT, a BCC is apparent as an
ovoid hypo-reflective formation with a darker
boundary and partially signal-free, cystic parts
compared to the surrounding hyper-reflective
stroma, or is visible as a lobule-like protrusion of
the epidermis. An alteration of the DEJ is also a
typical feature of BCC in OCT. Clinically, a BCC
can be diagnosed with a sensitivity of 59–90%
and a specificity of 75–90%, while with der-
moscopy and OCT a precision of 87.4% can be
achieved [2, 15]. Nevertheless, it is still difficult
to discriminate between BCC subtypes despite a
new proposed algorithm in high-definition
OCT [16–19]. As well as for initial diagnosis,
OCT is also used for treatment monitoring of
BCC [20–23].
As for every type of tumor, the extension and
growth of vessels are essential for the develop-
ment of non-melanoma skin cancer [24]. Due to
angiogenesis, the necessary nutrients and oxy-
gen reach the BCC and help to support its
growth. In BCC, there are two known forms of
blood vessels. The superficial arborizing vessels,
named teleangiectasia, can be recognized in
dermoscopy, while in the histopathological
examination multifocal superficial BCC are
displayed by light tissue and a higher vascular-
isation in the dermis between the multiple
tumor islands [25]. Both the superficial and the
deeper vascular networks in the dermis can be
Fig. 4 a BCC on the back (size: 6 mm 9 2 mm, cross-sec-
tional view). Extended vertical vessel columns can be seen
in superficial BCCs. b BCC on the nose
(size: 6 mm 9 6 mm, en face view). The skin depth of
the depicted image is 0.3 mm. The vessels in BCC show
changes in diameter and are distributed disorderly. The
broad pattern of the vasculature is located in the center
and around the edges of the tumor nests
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seen in the D-OCT images. First, the cross-sec-
tional D-OCT images show extended vertical
vessel columns in superficial BCC (Fig. 4a).
Second, the en face view visualizes the changes
in vessel diameters and the chaotic arrangement
of very small irregular vessels (Fig. 4b) [11].
There is a wide range of the vascular network in
BCC visible. Some vessels appear larger than
those seen in healthy skin and some look so
tiny and fragile that they would not have been
noticed if they were not depicted in red color. It
is obvious that the vessels are mainly located in
the center of the BCC, and sometimes it can be
seen that the vessels also seem to surround the
rims of the tumor nests (Fig. 4b) [6]. The
additional information regarding the vessel
morphology in BCCs provided by D-OCT may
be of value in non-invasively determining the
subtype and aggressiveness of the tumour, so
that more informed treatment decisions can be
made, especially in the context of non-invasive
treatment options.
Melanocytic Nevus and Malignant Melanoma
Due to the limitation of the image resolution, it
is difficult to evaluate melanocytic lesions in
conventional cross-sectional OCT images.
However, with D-OCT, it is necessary to observe
the vasculature of nevi or melanoma in hori-
zontal or even 3D views.
Fig. 5 a, b A dermal nevus on the right abdomen
(size: 6 mm 9 6 mm, en face (superficial and deeper)
view). The skin depth of the depicted image is 0.2 and
0.4 mm. Under the epidermis inside the mole, dotted
vessels are regularly distributed. If there is a deep dermal
involvement then sometimes a precise reticular pattern is
visible. c A seborrheic keratosis on the left breast
(size: 6 mm 9 6 mm, en face view). The skin depth of
the depicted image is 0.4 mm. Many regularly distributed
dotted, curved, and also coiled vessels are visible. d–f A
malignant melanoma on the left shoulder (size:
6 mm 9 6 mm, en face view). The skin depths of the
depicted image are 0.2, 0.3 and 0.4 mm. Clusters of vessel
dots and even blobs in the superficial dermis are diffusely
distributed. With increase in the tumor depth, the dots
seem to build linear formations. This invasive melanoma
shows long linear vessels of irregular size and distribution
with a branching architecture
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In nevi with accumulations of melanocytes
in the DEJ or in the superficial dermis, the
D-OCT shows a homogenous picture like in
healthy adjacent skin. Right below the epider-
mis inside the mole, sharply demarcated vessels
regularly organized in the form of dots are vis-
ible (Fig. 5a). If there is a deep dermal involve-
ment, then sometimes a delicate reticular
pattern can be noticed (Fig. 5b). In a suspected
dysplastic lesion, the vessels in the dermis are
larger and formed in characteristic curves,
reaching from bottom to top with regular fre-
quency. To visualize this aspect, a 3D image
must be constructed from the D-OCT dataset.
The tumor depth is directly proportional to the
length of the bowed vessels.
Because of the intra-epidermal growth of
melanomas, the tumors show scattered dis-
tributed clusters of vessel dots and even blobs in
the superficial dermis (Fig. 5d) [26]. However,
the deeper the tumor grows, the more that dots
seem to form linear figures (Fig. 5e). Highly
invasive melanomas consist of long, intense,
linear vessels that are of irregular size and dis-
tribution and show a branching pattern
(Fig. 5f). The latter is visualized as an arborizing
or bulging architecture. Especially in thick,
deeply invasive melanomas, the formation of
vessel aneurysms and multiple bizarrely and
irregularly shaped vessels are apparent. In 3D
view, it can be seen that these tumors build
‘spikes’, delicate perpendicular figures, which
reach up to the epidermal surface.
Our preliminary results indicate that D-OCT
reveals changes in vessel morphology as the
lesion progresses from dysplastic nevus to mel-
anoma in situ and then to more invasive mel-
anomas. We therefore speculate that D-OCT
might be useful in assessing disease progression
leading to earlier/more efficient interventions,
and also as a powerful research tool in under-
standing this disease. Further work is required
to confirm these ideas.
Seborrheic Keratosis
In structural OCT in the cross-sectional as well
as in the en face views, the pattern of gyri and
sulci is one typical criterion of seborrheic ker-
atoses. However, when looking at the vessels,
the benign character of the lesion is immedi-
ately obvious. There are many regularly dis-
tributed dotted, but also curved, and sometimes
even coiled vessels corresponding to the hair-
pin-like vessels, which can also be found in
dermoscopy (Fig. 5c).
Inflammatory and Degenerative Skin
Diseases
Skin diseases, which are caused due to inflam-
mation or degeneration, can show changes in
the size, amount, diameter and
Fig. 6 Psoriasis on the left elbow with a thickening of the
stratum corneum and the epidermis as well as visible
hypervascularisation: a size: 6 mm 9 2 mm, cross-sectional
view; b size: 6 mm 9 6 mm, en face view. The skin depth
in en face view is 0.3 mm. In the papillary dermis, the
extended vessel loops are apparent (arrows)
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three-dimensional structure of their blood ves-
sels. For example, erythematous skin arises
because of the vascular dilatation. In this con-
text, D-OCT may be of value in non-invasively
monitoring and measuring the effects of
treatments.
Psoriasis
Psoriatic skin shows hyperkeratosis, acanthosis,
pronounced regular rete ridges and dilated ves-
sels in the dermis, demonstrating the compo-
nents of inflammation, proliferation of the
epidermis and angiogenesis, which contribute
to the development of psoriasis. All of these
features are displayed in structural OCT, but,
especially with D-OCT, the typical vessel
capillary loops in the papillary dermis, named
spikes, are visible (Fig. 6a, b).
Scleroderma
In patients with systemic scleroderma, it is
known that this disease causes thickening and
hardening of the skin and impedes the micro-
circulation blood supply especially in the fin-
gertips [27–29]. Ring et al. found out that in
structural OCT the typical DEJ is missing and
the density of the dermis is enhanced along
with a disappearance of the skin appendages
[30]. As a result of the loss of blood vessels, the
acral parts of the body like the fingertips are no
longer supplied with blood leading to necrosis
and ulceration. A recent study discovered
Fig. 7 Comparison of a nail fold in a scleroderma patient
(a, b) with a normal nail fold in a healthy patient (c,
d) (size: 6 mm x 2 mm, cross-sectional view, size: 6 mm x 6
mm, en face view). A thickening of the epidermis and
dermis and a loss of the vasculature can be noticed in
scleroderma compared to normal skin. Despite that,
megacapillaries in the shape of a Y (white arrows) are
found in scleroderma, which take the place of the compact
network of small vessels seen in healthy skin
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megacapillaries in the shape of a Y with D-OCT
instead of the small vascular network, which
can be recognized in healthy nail folds [6, 30]
[Fig. 7 comparison of a scleroderma patient (a,
b) with a healthy skin fold (c, d)].
Wounds
The distinction between different types of
chronic wounds is often difficult. A biopsy will
probably lead to the final diagnosis, but is
counterproductive for delayed wound healing.
To investigate the healing process, biopsy is not
the ideal way to do this, because, once the tissue
sample is taken, repeated biopsies are not pos-
sible in the same location. Through the use of
D-OCT, in vivo insight into the wound with its
newly proliferating vessels enables multiple
non-invasive ‘‘biopsies’’ from several locations
which may provide full monitoring of the
continuous wound healing process like no other
available device [31, 32].
In particular in chronic venous insufficiency,
different stages of vascularisation are visible.
The adjacent normal skin in the surrounding
Fig. 8 Patient with a chronic venous ulcer on the lower
extremity (size: 6 mm 9 2 mm, cross-sectional view, size:
6 mm 9 6 mm, en face view). a Adjacent normal skin in
the surrounding area of the ulcer with extended lymphatic
vessels without perfusion. b Dermatosclerotic skin with
minimal increase of dotted vessels. c The margin of the
ulcer shows larger vessel dots of higher density. d In the
middle of the ulcer, larger crowds of dotted vessels, called
blobs, due to granulation are visible
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area of the ulcer presents large, extended lym-
phatic vessels without perfusion (Fig. 8a). In
dermatosclerotic skin, there is only a minor
growth of dotted vessels in the sclerotic and
fibrous stroma (Fig. 8b). At the margin of the
ulcer, the vessels form dots of higher density
(Fig. 8c). In the middle of the wound itself,
granulation islands with larger aggregations of
vessels in the form of dots, blobs and coils are
apparent (Fig. 8d). It might therefore be possible
to use D-OCT to assess the healing status of
individual ulcers so that ‘chronic’ non-healing
ulcers can be quickly identified for earlier
intervention than is currently possible.
Moreover, D-OCT may help to evaluate the
depth of a burn wound and to determine whe-
ther the injury can be treated conservatively or
surgically [33–36]. Besides the structural infor-
mation on the amount of burned skin, D-OCT
shows the remaining and the thermolytically
affected blood vessels (Fig. 9a, b). This way, the
diagnostician may get an overall impression of
the extent of the burn injury by using D-OCT.
Scars
Scars are the end result of tissue repair. Thus,
there is still a difference between healthy skin
and scar tissue. Clinically scars can be painful or
itchy; they can be atrophic, hypertrophic or
even keloids, which exceed the original scar
area with their proliferation. Besides that, scars
are distinguishable from normal skin through
their color/pigmentation, structure, height in
the level of the skin, firmness and pliability.
Histopathologically, alterations in the vascular
network and in the epidermal structure can be
found in scar tissue, but collagen deposits,
fibrous tissue remodeling, inflammatory infil-
trations and sclerosis might also be present.
All these criteria need to be considered for
the evaluation of scars. Nevertheless,only
Fig. 9 Burn injury grade IIa with a subepidermal blister on the knee: a size: 6 mm 9 2 mm, cross-sectional view; b size:
6 mm 9 6 mm, en face view. Below the bulla, the presence of active blood vessels indicates a burn wound grade IIa
Fig. 10 Scar on the right temple (size: 6 mm 9 6 mm, en
face view). Scars show a lot more vessels and in a streaming
pattern, which means the blood vessels are aligned parallel
to each other
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Fig. 11 a, b Cheek of a rosacea patient
(size: 6 mm 9 6 mm, en face view). The skin depths in
en face view are 0.2 mm and 0.4 mm. a Small dotted
vessels in superficial skin layers represent the erythema.
b The broad vascular network visualizes the teleangiectasia
(a, b). c, d Cheek of a healthy person (size: 6 mm 9 6 mm,
en face view). The skin depth in en face view is 0.4 mm.
Superficial blood vessels before (c) and after (d) the
application of topical brimonidine. After treatment, a
vascular constriction is visible (d). e, f Cheek of a rosacea
patient (size: 6 mm 9 6 mm, en face view). The skin
depth in en face view is 0.4 mm. The former broad
vascular network (e) is replaced by a fuzzy appearance after
dye laser therapy (f)
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subjective scores are available and objective
parameters are missing [37, 38]. Moreover, scars
after burn injury were objectively explored with
OCT by Gong et al. [37, 39] and Liew et al. [40]
through automated quantification of the den-
sity and diameter of the vasculature using
speckle decorrelation and the attenuation coef-
ficient [37, 39, 40]. The result is that inside the
scar tissue the density of blood vessels is
increased and that there is no typical vascular
network formation like in healthy skin, but a
parallel organization of the vasculature
(Fig. 10). More effective characterization of scars
with D-OCT may lead to more accurate
treatments.
Evaluation of Treatment Effects
D-OCT is also a useful device for the visualiza-
tion and evaluation of treatment effects. Rosa-
cea patients often show erythema and
teleangiectasia, because of the dilatation of thin
superficial blood vessels. Erythema is visualized
in D-OCT as small dotted vessels in superficial
skin layers and, in deeper levels, the teleang-
iectasia show a network of vessels with a
broader diameter than in healthy skin (Fig. 11a,
b). There are treatment options to reduce these
alterations by the mechanism of vasoconstric-
tion. With D-OCT, it is possible to observe the
superficial blood vessel changes in erythe-
mato-teleangiectatic rosacea, and also in nor-
mal skin, which were locally treated with
brimonidine gel 0.33% [41, 42] (Fig. 11c, d).
This is a selective a2-adrenergic receptor agonist,
which peripherally constricts the superficial
vessels [41, 42].
In rosacea, both the superficial and the dee-
per vascular network are affected by the disease.
Since there is a limitation in the penetration for
the topical treatment with brimonidine, dye
laser therapy is used for the coagulation of
deeper blood vessels. In D-OCT, the former
broad vascular network is replaced by a fuzzy
appearance of the treated vasculature (Fig. 11e,
f). Ring et al. proved that, through intense
pulsed light therapy, the microvascular
destruction can be imaged even by structural
OCT [43]. Using D-OCT, these vascular changes
can be quantitatively evaluated before and after
topical brimonidine as well as laser treatment.
CONCLUSIONS
Dynamic OCT is a new and powerful unique
tool of investigating in vivo blood vessels of
superficial skin layers. The pattern of perfusion
plays an important role not only in inflamma-
tory skin diseases but also in skin tumors.
Neo-angiogenesis is a typical feature of neo-
plastic tumors, and metastases occur via lym-
phatic and blood vessels. Our studies on actinic
keratoses, squamous cell carcinomas, Bowen’s
disease and basal cell carcinomas exhibited dif-
ferent patterns of vasculature between the
entities as well as changes corresponding to
tumor invasion. In melanomas, an increased
vasculature with atypical branching was found.
Further studies are necessary to correlate the
degree of vessel atypia with the risk of metas-
tasis. If this is proven, D-OCT might enable
earlier and more accurate treatment for
improved patient outcomes.
Other interesting fields for D-OCT are wound
healing and pharmacologic effects. We could
demonstrate that pharmacologic effects on
perfusion can be easily quantified and moni-
tored over time using D-OCT. Furthermore,
inflammatory and degenerative skin diseases as
well as acute and chronic wounds show char-
acteristic changes of the blood vessels, allowing
for quantification and monitoring of these dis-
eases in a non-invasive way.
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